Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Professional Topics

Subcategories:Career DevelopmentInterprofessional PerspectivePresident's PerspectiveProfilesRheuminations

2017 ACR/ARHP Award Winners Advance Rheumatology, Part 1

Richard Quinn  |  December 17, 2017

SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego last month, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ACR winners about their individual contributions to advancing rheumatology. In coming issues, we…

Incoming ACR President Dr. David Daikh Considers Serving Organization an Honor and Privilege

David Daikh, MD, PhD  |  December 17, 2017

Following the 2017 ACR/ARHP Annual Meeting when the formal transition in volunteer leadership occurred, my overwhelming thought has been that it is an honor and privilege to serve you as the 81st president of the ACR. Honor stems from the heritage of excellence and progress that defines this organization. Privilege comes from the opportunity to…

A History of the Science, Treatment of Rheumatologic Illnesses from Gold to Gene Therapy

Simon M. Helfgott, MD  |  December 17, 2017

Mysterious Ways The juxtaposition of the old and the new was readily evident that busy Wednesday morning. My first patient, a 94-year-old gentleman, Hal, arrived with a precise request. His rheumatologist for the past 40 years had just retired, and he was searching for a doctor with expertise in the use of gold sodium aurothioglucose,…

What Makes an Effective Department Head?

Karen Appold  |  December 8, 2017

If you’re aspiring to lead a rheumatology department, you will need more than what you learned in medical school. Beyond expertly treating patients and participating in research, these leaders must also understand management, mentorship and problem solving, as well as the business of running a successful department…

Meet Sandra Mintz, MSN, RN, Incoming ARHP President: Personal Challenges Fuel Persistence, Passion for the Job

Kelly Tyrrell  |  December 5, 2017

Sandra Mintz, MSN, RN, knew in high school that she wanted to be a nurse, and upon graduation, she did just that, the youngest in her class to graduate from Pasadena City College with an Associate of Science in nursing. Not long after embarking on her career, she received a life-altering medical diagnosis of her…

The Rheumatology Clinical Registry Is Now Open for Reporting

From the College  |  December 5, 2017

The Rheumatology Clinical Registry (RCR) is open for reporting. As we are approaching the end of the 2017 MIPS performance year, however, keep in mind that to report via the RCR, your last date to enter patient information will be Jan. 15, 2018. You can access the RCR’s updated dashboard here. Remember to use your…

The ACR Lobbies Against New Part B Drug Cost Adjustment Rule

Carina Stanton  |  December 5, 2017

The ACR and a number of other physician medical associations are lobbying for an immediate legislative fix to a piece of the MACRA law that factors high-cost Part B drugs into a rheumatology practice’s Medicare reimbursement rate through the Merit-Based Incentive Payment System (MIPS). This change, which goes into effect immediately, will impact practices in…

Consumers with High-Deductible Health Plans Could Be Smarter Shoppers

Lisa Rapaport  |  November 30, 2017

(Reuters Health)—Even when consumers have health plans that require them to pay a high amount out-of-pocket for care, they often don’t talk to doctors about the price of treatments or shop around to get the best deal, a U.S. study suggests. Researchers focused on high-deductible health plans, which typically have lower monthly premiums than other…

Sen. Lisa Murkowski Addresses Rheumatologists During ACR/ARHP Annual Meeting, Tax Reform & More

Angus Worthing, MD, FACP, FACR   |  November 21, 2017

Greetings, advocates! This month’s Washington update covers how Congress’s tax proposals affect rheumatology, the ACR’s plan to fight Medicare’s adjustments to Part B drug costs in MIPS, the good news of Medicare’s new individualized biosimilar reimbursement, advances in the rheumatology-specific Alternative Payment Model and developments in Congress’s awareness about the perilous pharmacy benefit manager system….

Biosimilars Great Debate: To Switch or Not?

Susan Bernstein  |  November 17, 2017

SAN DIEGO—Should patients with rheumatic diseases switch from a biologic to its biosimilar? At the 2017 ACR/ARHP Annual Meeting’s Great Debate, held Nov. 5, two rheumatologists argued whether to switch or stay put based on safety, efficacy and potential cost savings. First to the podium to make the case for switching, Jonathan Kay, MD, tweaked…

  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 227
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences